Metraipolis › archive › dc_ed643d60a75f

Status and outlook of mRNA therapeutics for viral diseases — Europe PMC PMID:41673122

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41673122
DOI
10.1038/s44321-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-05T22:21:54.857Z
SHA-256 of the archived text
3ef6c5c7a27e6fbbe364613e3c289b17ead7168d14c566ad06c4802a1201cc47
Stable URL of this page
https://metraipolis.com/documento/dc_ed643d60a75f

How to cite

Status and outlook of mRNA therapeutics for viral diseases — Europe PMC PMID:41673122 — Europe PMC (en), https://europepmc.org/article/MED/41673122 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed643d60a75f (Metraipolis archive dc_ed643d60a75f, sha256 3ef6c5c7a27e6fbbe364613e3c289b17ead7168d14c566ad06c4802a1201cc47)
BibTeX
@misc{dced643d60a75f,
  title = {Status and outlook of mRNA therapeutics for viral diseases — Europe PMC PMID:41673122},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41673122},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed643d60a75f; sha256 3ef6c5c7a27e6fbbe364613e3c289b17ead7168d14c566ad06c4802a1201cc47},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41673122. Agents can read the archived copy with the MCP tool read_document.